Astellas and OSI: Major Japanese Pharma Companies Continue to Upgrade Their U.S. Presence and Oncology Portfolios - On Demand

Decision Resources is offering an exclusive Pharmaview competitive assessment entitled Astellas and OSI: Major Japanese Pharma Companies Continue to Upgrade Their U.S. Presence and Oncology Portfolios. This session is ONLY available to Pharmaview subscribers.

This webinar was held on June 3, 2010. Contact us to learn how you can become a Pharmaview subscriber and access a recorded playback of this event.

Click here to view the invite.